Zurcher Kantonalbank (Zurich Cantonalbank) Sage Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 13,320 shares of SAGE stock, worth $72,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,320

Previous 13,320 -0.0%

Holding current value

$72,460

Previous $96,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$18.62 - $26.95 $19,811 - $28,674	1,064 Added 8.68%	13,320 $249,000
Q4 2023 Jan 30, 2024	BUY	$17.1 - $22.26 $50,735 - $66,045	2,967 Added 31.94%	12,256 $265,000
Q3 2023 Oct 25, 2023	BUY	$16.75 - $48.98 $23,031 - $67,347	1,375 Added 17.37%	9,289 $191,000
Q1 2023 May 08, 2023	BUY	$37.27 - $46.57 $57,544 - $71,904	1,544 Added 24.24%	7,914 $332,000
Q4 2022 Feb 01, 2023	SELL	$32.2 - $43.61 $40,282 - $54,556	-1,251 Reduced 16.42%	6,370 $242,000
Q2 2022 Aug 09, 2022	SELL	$27.52 - $37.99 $1,871 - $2,583	-68 Reduced 0.88%	7,621 $246,000
Q1 2022 Apr 21, 2022	BUY	$30.71 - $45.71 $2,886 - $4,296	94 Added 1.24%	7,689 $255,000
Q4 2021 Feb 01, 2022	BUY	$37.06 - $47.11 $48,919 - $62,185	1,320 Added 21.04%	7,595 $323,000
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $523 - $745	-13 Reduced 0.21%	6,275 $278,000
Q2 2021 Jul 30, 2021	BUY	$54.88 - $79.29 $1,865 - $2,695	34 Added 0.54%	6,288 $357,000
Q1 2021 May 03, 2021	SELL	$70.65 - $96.76 $31,227 - $42,767	-442 Reduced 6.6%	6,254 $468,000
Q4 2020 Jan 28, 2021	SELL	$58.41 - $89.06 $31,307 - $47,736	-536 Reduced 7.41%	6,696 $579,000
Q2 2020 Jul 28, 2020	BUY	$25.95 - $43.15 $80,263 - $133,462	3,093 Added 74.73%	7,232 $301,000
Q1 2020 May 06, 2020	BUY	$26.15 - $77.24 $20,004 - $59,088	765 Added 22.67%	4,139 $119,000
Q3 2019 Oct 18, 2019	BUY	$140.29 - $189.96 $14,449 - $19,565	103 Added 3.15%	3,374 $473,000
Q2 2019 Jul 30, 2019	BUY	$157.85 - $183.09 $26,045 - $30,209	165 Added 5.31%	3,271 $599,000
Q1 2019 Apr 29, 2019	BUY	$89.33 - $163.65 $15,632 - $28,638	175 Added 5.97%	3,106 $494,000
Q3 2018 Nov 09, 2018	BUY	$138.11 - $169.04 $29,831 - $36,512	216 Added 7.96%	2,931 $414,000
Q2 2018 Aug 06, 2018	SELL	$140.36 - $175.76 $15,720 - $19,685	-112 Reduced 3.96%	2,715 $425,000
Q1 2018 May 03, 2018	BUY	$152.15 - $192.33 $113,960 - $144,055	749 Added 36.04%	2,827 $455,000
Q4 2017 Jan 31, 2018	BUY	$60.72 - $167.34 $42,504 - $117,138	700 Added 50.8%	2,078 $342,000
Q3 2017 Nov 08, 2017	BUY	$61.4 - $88.52 $84,609 - $121,980	1,378	1,378 $86,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Sage Therapeutics, Inc. Transaction History